AcquisitionOther
GLOBALINK INVESTMENT INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
GLOBALINK INVESTMENT INC. -> target · $1.6 billion
Since its inception in 2017, Alps has evolved into an integrated platform consisting of biotechnology research, medical and wellness portfolios aiming to deliver personalized, precise and preventive medicine.
Open source record (SEC) ↗